More MS news articles for Sep 2001

MS patientsí Quality of Life Not Indicated by Neurological Exams

FaxWatch Inc.- September 14, 2001

MS patients' quality of life cannot be predicted from the results of neurological exams or tests of disability, researchers found.

In a recent study that involved 29 people with secondary progressive MS, patients were given Bristol-Myers Squibb Co.'s Taxol (paclitaxel) for six months.

The researchers did not find a consistent correlation between overall quality-of-life scores and MRI outcomes, scores on the Expanded Disability Status Scale or scores on the MS Functional Composite.

Patients' quality-of-life scores were strongly linked to their emotional well-being and distress about their health, as well as their overall physical condition.

The study appears in the September issue of Neurology.

To see more of FaxWatch, or to subscribe, go to

Copyright 2000 FaxWatch Inc